Thrombolex Inc.

Founded in 2016, Thrombolex, Inc. is engaged in the design, development, manufacture and distribution of innovative endovascular catheters.

01/13/2026

The BASHIR™ S-B Endovascular Catheter features a shorter infusion basket for smaller vessels, enabling precise thrombolytic infusion tailored to each patient’s anatomy. Designed for flexibility and control, it supports targeted therapy with procedural efficiency.

Thrombolex.com

01/01/2026

Happy New Year from Thrombolex.

Thrombolex.com

12/30/2025

Dr Barry Bertolet discusses that, with an intuitive design and minimal learning curve, the BASHIR™ Endovascular Catheter makes PE treatment straightforward, empowering more physicians to deliver life-saving care quickly and confidently.

Thrombolex.com

12/26/2025

To all who celebrate, Thrombolex wishes you a Happy Kwanzaa.

Thrombolex.com

12/25/2025

Thrombolex wishes a Merry Christmas to all who are celebrating.

Thrombolex.com

12/23/2025

To everyone celebrating this month, Thrombolex wishes you a safe and joyful holiday season. We are grateful for the clinicians, partners, and patients who inspire our mission to advance care through targeted, effective solutions.

Thrombolex.com

12/19/2025

Thrombolex remains committed to developing therapies that deliver safe and efficient treatment for A&VTE. Through our evidence-based approach, we strive to continually improve better patient outcomes with precision and safety.

Thrombolex.com

12/16/2025

Our novel technology empowers physicians to do more with less for their patients. The BASHIR™ Endovascular Catheter's dual action capability enables the safe, efficient mechanical impact on the thrombus while delivering low-dose thrombolytics When you need it, where you need it, as much as necessary, as little as possible.

Thrombolex.com

12/15/2025

Thrombolex wishes a Happy Hanukkah to all who are celebrating.

Thrombolex.com

12/04/2025

In the RESCUE-II Study, the BASHIR™ Endovascular Catheter achieved a 29.2% reduction in pulmonary artery obstruction with no ICU infusion required. These results highlight our commitment to safe, effective, single-session therapies that support positive clinical outcomes.

Thrombolex.com

12/01/2025

Safe. Fast. Easy to use. The BASHIR™ Endovascular Catheter helps physicians do more for their patients in a single session when treating PE. This innovative device helps address PE cost-effectively while improving patient outcomes.

Thrombolex.com

11/30/2025

In the RESCUE-II study, the BASHIR™ Endovascular Catheter delivered targeted, low-dose r-tPA directly into each pulmonary artery, completing treatment in just 39 minutes on-the-table. Imaging at 48 hours showed a 22.3% reduction in RV/LV ratio and a 29.2% drop in pulmonary artery obstruction, achieved with no ICU infusions and zero major bleeding events. These outcomes illustrate how real-world protocols can streamline acute PE care while prioritizing safety and efficacy.

Thrombolex.com

Address

75 Britain Drive
New Britain, PA
18901

Telephone

+18447926300

Website

http://www.thrombolex.com/

Alerts

Be the first to know and let us send you an email when Thrombolex Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Thrombolex Inc.:

Shortcuts

Want your practice to be the top-listed Clinic in New Britain?